• Fandifi (FDM) has launched a new website designed to focus on an inbound marketing campaign using search intent-driven content
  • The company’s aim for the new website is to help Fandifi rank itself better with SEO
  • It will provide the audience with the information they need in a timely and relevant manner regarding their favourite types of Fandifi’d content
  • Fandifi operates an Esports/Sports wagering platform
  • Fandifi Technology Corp. (FDM) is up 10.00 per cent, trading at C$0.055 per share at 1:11 pm ET

Fandifi (FDM) has launched a new website designed to focus on an inbound marketing campaign using search intent-driven content.

The company’s aim for the new website is to help Fandifi rank itself better with SEO.

Fandifi updated that the website is optimized to provide a seamless user experience, with a clean and modern design that makes it easy to navigate. The website’s content is organized for search engines and is tailored to match the search intent of the users.

This will enable Fandifi to better engage with its target audience. It will provide the audience with the information they need in a timely and relevant manner regarding their favourite types of Fandifi’d content.

David Vinokurov, CEO of Fandifi, commented on the news.

“We are excited to launch our new website, which is a major step forward for Fandifi’s marketing efforts. Our goal is to provide fans with the best possible online experience. This new website is a key part of our strategy to achieve that. We believe that by focusing on inbound marketing and search intent-driven content, we will be able to better connect with our target audience. This will drive more viewership to the content on our platform as part of our organic marketing efforts.”

Fandifi operates an Esports/Sports wagering platform. The company’s platform runs on associated neural networks tailor-made for content creators to increase the gamification of their content.

Fandifi Technology Corp. (FDM) is up 10.00 per cent, trading at C$0.055 per share at 1:11 pm ET.


More From The Market Online

@ the Bell: TSX recovers and S&P hits fresh high

Energy shares led enough of a rally to overcome industrials and tech losses to push the TSX to a positive end on Tuesday.

Pathologists group accepts Telo Genomics’ test for rare blood cancer

The College of American Pathologists accepts the Telo Genomics' (TSXV:TELO) submission of a test for a rare blood cancer.

Theralase adds cancer immunotherapy to potential revenue streams

Theralase Technologies' (TSXV:TLT) lead drug candidate, Rutherrin, enhanced cancer immunotherapy in a pre-clinical setting.